Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Verrica Pharmaceuticals Stock Is Getting Pummeled Today

TheMotleyFool

0 0

Why Verrica Pharmaceuticals Stock Is Getting Pummeled TodayPhoto, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

Shares of Verrica Pharmaceuticals (NASDAQ: VRCA), a clinical-stage biopharmaceutical company, are tumbling after the company disclosed a complete response letter for VP-102. Investors unhappy with the delay pushed the stock 23.4% lower this morning but the stock has recovered a little. As of 11:42 a.m. EDT on Tuesday, the stock was down 11.3% from yesterday's closing price.

Without any approved products to sell yet, Verrica Pharmaceuticals burned through $12.7 million in the second quarter alone. Investors were hoping sales of VP-102 would begin offsetting those losses.

Image source: Getty Images.

Source Fool.com

Like: 0

VRCA

Teilen